Investigating therapies of potentially great benefit: ECMO. With comments and a rejoinder by the author

DOI10.1214/ss/1177012384zbMath0955.62638OpenAlexW2023461636MaRDI QIDQ1595997

Publication date: 7 February 2001

Published in: Statistical Science (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1214/ss/1177012384

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Related Items (26)

Exact statistical power for response adaptive designs ⋮ An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score ⋮ Bayesian robustness in bidimensional models: Prior independence. (With discussion) ⋮ Efficient randomized-adaptive designs ⋮ Some tests for differences between proportions where the expected number of exposures to an inferior treatment is kept small ⋮ Optimal target allocation proportion for correlated binary responses in a \(2{\times}2\) setup ⋮ Classes of bidimensional priors specified on a collection of sets: Bayesian robustness ⋮ Sequential and Two-Stage Fixed-Width Confidence Interval Estimation in Response-Adaptive Designs ⋮ Sensitivity to prior independence via farlie-gumbel-morgenstern model ⋮ Clinician preferences and the estimation of causal treatment differences. (With comments) ⋮ Sequential procedures for comparing several medical treatments ⋮ Bayesian adaptive randomization with compound utility functions ⋮ Response-adaptive randomization in clinical trials: from myths to practical considerations ⋮ GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT ⋮ Herbert Robbins and sequential analysis ⋮ Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress ⋮ Ethical issues in oncology biostatistics ⋮ The doubly adaptive weighted differences design ⋮ Block unimodality for multivariate Bayesian robustness ⋮ Adjusted likelihoods for synthesizing empirical evidence from studies that differ in quality and design: effects of environmental tobacco smoke ⋮ A Bayesian adaptive design for two-stage clinical trials with survival data ⋮ Contribution of Milton Sobel in Selection Problem Following Ethical Allocation ⋮ A class of adaptive designs ⋮ Applying non-parametric robust Bayesian analysis to non-opinionated judicial neutrality ⋮ Analysis of homogeneity of treatment effect in adaptive multicenter clinical trials ⋮ A conversation with Nancy Flournoy

This page was built for publication: Investigating therapies of potentially great benefit: ECMO. With comments and a rejoinder by the author